ONCOLife Articles
The Integration of START and CURC Could Play a Pivotal Role in Advancing Clinical Trials
ONCOLife | 20 June 2025
TROPION-Breast01: Redefining Treatment for HR+/HER2– Metastatic Breast Cancer
ONCOLife | 18 June 2025
The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines
ONCOLife | 29 August 2025
FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGF+ Lung Cancer
FDA & EMA | 20 August 2025
First Patient Enrolled for Aliya® PEF Tumor Ablation of Lung/Liver Soft-Tissue Lesions
ONCOLife | 18 August 2025
Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells
ONCOLife | 17 August 2025
Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission
ONCOLife | 15 August 2025
PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer
ONCOLife
12 August 2025
Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer
ONCOLife
9 August 2025
Epcoritamab + R2 Achieves 95.7% ORR, Cuts Risk by 79% in R/R Follicular Lymphoma
ONCOLife
8 August 2025
FDA Approves Modeyso as First-Ever Therapy for Pediatric Brain Tumor, H3 K27M+ Glioma
FDA & EMA
6 August 2025
New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission
ONCOLife
2 August 2025
2025 Pan-Mass Challenge Draws Thousands of Cyclists to Fuel Next Era of Cancer Research
ONCOLife
3 August 2025
Targeting eIF2A to Halt Melanoma: Study Reveals Key Driver of Cancer Cell Migration
ONCOLife
2 August 2025
New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer
ONCOLife
1 August 2025
Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment
ONCOLife
1 August 2025
Global Data Warns of Secondary Cancers Linked to CAR-T Therapy, Urging Monitoring
ONCOLife
31 July 2025
Artificial Sweetener Sucralose May Undermine Cancer Immunotherapy, Study Finds
ONCOLife
31 July 2025
First Non-Invasive Endometrial Cancer Detection Test, EdenDx, Launched by Gnosis
ONCOLife
31 July 2025
Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment
ONCOLife
30 July 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
